{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:57:09Z","timestamp":1790657829953,"version":"4.1.0"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-026-01972-z","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:23:00Z","timestamp":1790655780000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unraveling the role of FGF21 in epilepsy disease: mechanistic insights and therapeutic Potential"],"prefix":"10.1007","volume":"41","author":[{"given":"Gaurav","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadga Raj","family":"Aran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"1972_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.600050","volume":"12","author":"IA Ademuwagun","year":"2021","unstructured":"Ademuwagun IA, Rotimi SO, Syrbe S, Ajamma YU, Adebiyi E (2021) Voltage gated sodium channel genes in epilepsy: mutations, functional studies, and treatment dimensions. Front Neurol 12:600050. https:\/\/doi.org\/10.3389\/fneur.2021.600050","journal-title":"Front Neurol"},{"issue":"3","key":"1972_CR2","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.3390\/ijms24031869","volume":"24","author":"FL Andronie-Cioara","year":"2023","unstructured":"Andronie-Cioara FL, Ardelean AI, Nistor-Cseppento CD, Jurcau A, Jurcau MC, Pascalau N, Marcu F (2023) Molecular mechanisms of neuroinflammation in aging and Alzheimer\u2019s disease progression. Int J Mol Sci 24(3):1869. https:\/\/doi.org\/10.3390\/ijms24031869","journal-title":"Int J Mol Sci"},{"issue":"15","key":"1972_CR3","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.2174\/1381612054021006","volume":"11","author":"JA Armijo","year":"2005","unstructured":"Armijo JA, Shushtarian M, Valdizan EM, Cuadrado A, Adin J (2005) Ion channels and epilepsy. Curr Pharm Des 11(15):1975\u20132003. https:\/\/doi.org\/10.2174\/1381612054021006","journal-title":"Curr Pharm Des"},{"key":"1972_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176851","volume":"980","author":"GA Badawi","year":"2024","unstructured":"Badawi GA, Shokr MM, Elshazly SM, Zaki HF, Mohamed AF (2024) Sigma-1 receptor modulation by clemastine highlights its repurposing as neuroprotective agent against seizures and cognitive deficits in PTZ-kindled rats. Eur J Pharmacol 980:176851. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176851","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"1972_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrd2792","volume":"8","author":"A Beenken","year":"2009","unstructured":"Beenken A, Mohammadi M (2009) The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov 8(3):235\u2013253. https:\/\/doi.org\/10.1038\/nrd2792","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"1972_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/14712598.2024.2436094","volume":"25","author":"U Binder","year":"2025","unstructured":"Binder U, Skerra A (2025) Strategies for extending the half-life of biotherapeutics: successes and complications. Expert Opin Biol Ther 25(1):93\u2013118. https:\/\/doi.org\/10.1080\/14712598.2024.2436094","journal-title":"Expert Opin Biol Ther"},{"key":"1972_CR116","doi-asserted-by":"publisher","unstructured":"Bottani E, Lamperti C, Prigione A, Tiranti V, Persico N, Brunetti D (2020) Therapeutic approaches to treat mitochondrial diseases:one-size-fits-all and precision medicine strategies. Pharmaceutics12(11):1083. https:\/\/doi.org\/10.3390\/pharmaceutics12111083","DOI":"10.3390\/pharmaceutics12111083"},{"issue":"10","key":"1972_CR7","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3390\/ph14101057","volume":"14","author":"A Cano","year":"2021","unstructured":"Cano A, Fonseca E, Ettcheto M, S\u00e1nchez-L\u00f3pez E, de Rojas I, Alonso-Lana S, Morato X, Souto EB, Toledo M, Boada M, Marquie M (2021) Epilepsy in neurodegenerative diseases: related drugs and molecular pathways. Pharmaceuticals 14(10):1057. https:\/\/doi.org\/10.3390\/ph14101057","journal-title":"Pharmaceuticals"},{"issue":"17","key":"1972_CR8","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1089\/neu.2017.5271","volume":"35","author":"J Chen","year":"2018","unstructured":"Chen J, Hu J, Liu H, Xiong Y, Zou Y, Huang W, Shao M, Wu J, Yu L, Wang X, Wang X (2018) FGF21 protects the blood\u2013brain barrier by upregulating PPAR\u03b3 via FGFR1\/\u03b2-klotho after traumatic brain injury. J Neurotrauma 35(17):2091\u20132103. https:\/\/doi.org\/10.1089\/neu.2017.5271","journal-title":"J Neurotrauma"},{"key":"1972_CR9","doi-asserted-by":"publisher","unstructured":"Chen C, Zhao Y, Lian Y, Hou Y, Gong L, Wu T, Yang Y, Zhu J, Wang X, Zhang K, Ding J (2026) 6 fatty acid binding protein 5 mediates astrocytic pyroptosis and neuroinflammation in epilepsy via cGAS\/STING pathway. Adv Sci:e76377. https:\/\/doi.org\/10.1002\/advs.76377","DOI":"10.1002\/advs.76377"},{"issue":"1","key":"1972_CR10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s10072-025-08623-8","volume":"47","author":"CE Cicero","year":"2026","unstructured":"Cicero CE, Angelini L, Abbadessa G, Bruno M, Fiume G, Nucera B, Ornello R, Arabia G, Giuliano L, Guarnieri B, Lugaresi A (2026) Sex and gender-related differences in neurological diseases: current challenges and recommendations for clinical practice. Neurol Sci 47(1):108. https:\/\/doi.org\/10.1007\/s10072-025-08623-8","journal-title":"Neurol Sci"},{"key":"1972_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2022.101564","volume":"64","author":"KE Claflin","year":"2022","unstructured":"Claflin KE, Sullivan AI, Naber MC, Flippo KH, Morgan DA, Neff TJ, Jensen-Cody SO, Zhu Z, Zingman LV, Rahmouni K, Potthoff MJ (2022) Pharmacological FGF21 signals to glutamatergic neurons to enhance leptin action and lower body weight during obesity. Mol Metab 64:101564. https:\/\/doi.org\/10.1016\/j.molmet.2022.101564","journal-title":"Mol Metab"},{"issue":"14","key":"1972_CR12","doi-asserted-by":"publisher","first-page":"eabn7105","DOI":"10.1126\/sciadv.abn7105","volume":"8","author":"M Croon","year":"2022","unstructured":"Croon M, Szczepanowska K, Popovic M, Lienkamp C, Senft K, Brandscheid CP, Bock T, Gnatzy-Feik L, Ashurov A, Acton RJ, Kaul H (2022) FGF21 modulates mitochondrial stress response in cardiomyocytes only under mild mitochondrial dysfunction. Sci Adv 8(14):eabn7105. https:\/\/doi.org\/10.1126\/sciadv.abn7105","journal-title":"Sci Adv"},{"key":"1972_CR118","doi-asserted-by":"crossref","unstructured":"Cui X, Sun Q, Wang H (2025) Targeting fibroblast growth factor (FGF)-21: a promising strategy for metabolic dysfunction-associated steatotic liver disease treatment. Frontiers in Pharmacology 16:1510322","DOI":"10.3389\/fphar.2025.1510322"},{"issue":"11","key":"1972_CR13","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.3390\/cells10112898","volume":"10","author":"A De Gaetano","year":"2021","unstructured":"De Gaetano A, Solodka K, Zanini G, Selleri V, Mattioli AV, Nasi M, Pinti M (2021) Molecular mechanisms of mtDNA-mediated inflammation. Cells 10(11):2898. https:\/\/doi.org\/10.3390\/cells10112898","journal-title":"Cells"},{"issue":"11","key":"1972_CR14","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.tips.2024.09.004","volume":"45","author":"D Debanne","year":"2024","unstructured":"Debanne D, Mylonaki K, Musella ML, Russier M (2024) Voltage-gated ion channels in epilepsies: circuit dysfunctions and treatments. Trends Pharmacol Sci 45(11):1018\u20131032. https:\/\/doi.org\/10.1016\/j.tips.2024.09.004","journal-title":"Trends Pharmacol Sci"},{"key":"1972_CR15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ijsu.2015.08.029","volume":"36","author":"AB Dixit","year":"2016","unstructured":"Dixit AB, Tripathi M, Chandra PS, Banerjee J (2016) Molecular biomarkers in drug-resistant epilepsy: facts & possibilities. Int J Surg 36:483\u2013491. https:\/\/doi.org\/10.1016\/j.ijsu.2015.08.029","journal-title":"Int J Surg"},{"issue":"2","key":"1972_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cytogfr.2005.01.001","volume":"16","author":"VP Eswarakumar","year":"2005","unstructured":"Eswarakumar VP, Lax I, Schlessinger J (2005) Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16(2):139\u2013149. https:\/\/doi.org\/10.1016\/j.cytogfr.2005.01.001","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"1972_CR17","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1007\/s12640-019-00151-6","volume":"37","author":"X Fang","year":"2020","unstructured":"Fang X, Ma J, Mu D, Li B, Lian B, Sun C (2020) FGF21 protects dopaminergic neurons in Parkinson\u2019s disease models via repression of neuroinflammation. Neurotox Res 37(3):616\u2013627. https:\/\/doi.org\/10.1007\/s12640-019-00151-6","journal-title":"Neurotox Res"},{"issue":"4","key":"1972_CR18","doi-asserted-by":"publisher","first-page":"4743","DOI":"10.1007\/s12035-024-04549-y","volume":"62","author":"M Fang","year":"2025","unstructured":"Fang M, Lu L, Lou J, Ou J, Yu Q, Tao X, Zhu J, Lin Z (2025) FGF21 alleviates hypoxic-ischemic white matter injury in neonatal mice by mediating inflammation and oxidative stress through PPAR-\u03b3 signaling pathway. Mol Neurobiol 62(4):4743\u20134768. https:\/\/doi.org\/10.1007\/s12035-024-04549-y","journal-title":"Mol Neurobiol"},{"issue":"11","key":"1972_CR19","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.3390\/cells10113242","volume":"10","author":"M Farooq","year":"2021","unstructured":"Farooq M, Khan AW, Kim MS, Choi S (2021) The role of fibroblast growth factor (FGF) signaling in tissue repair and regeneration. Cells 10(11):3242. https:\/\/doi.org\/10.3390\/cells10113242","journal-title":"Cells"},{"issue":"18","key":"1972_CR20","doi-asserted-by":"publisher","first-page":"14101","DOI":"10.3390\/ijms241814101","volume":"24","author":"BL Farrugia","year":"2023","unstructured":"Farrugia BL, Melrose J (2023) The glycosaminoglycan side chains and modular core proteins of heparan sulphate proteoglycans and the varied ways they provide tissue protection by regulating physiological processes and cellular behaviour. Int J Mol Sci 24(18):14101. https:\/\/doi.org\/10.3390\/ijms241814101","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1972_CR21","doi-asserted-by":"publisher","first-page":"e203","DOI":"10.1016\/s2468-2667(24)00302-5","volume":"10","author":"VL Feigin","year":"2025","unstructured":"Feigin VL, Vos T, Nair BS, Hay SI, Abate YH, Abd Al Magied AH, Abd ElHafeez S, Abdelkader A, Abdollahifar MA, Abdullahi A, Aboagye RG (2025) Global, regional, and national burden of epilepsy, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. Public Health 10(3):e203\u2013e227. https:\/\/doi.org\/10.1016\/s2468-2667(24)00302-5","journal-title":"The Lancet. Public Health"},{"issue":"1","key":"1972_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-physiol-021115-105339","volume":"78","author":"FM Fisher","year":"2021","unstructured":"Fisher FM, Maratos-Flier E (2021) Understanding the physiology of FGF21. Ann Rev Physiol 78(1):223\u2013241. https:\/\/doi.org\/10.1146\/annurev-physiol-021115-105339","journal-title":"Ann Rev Physiol"},{"key":"1972_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/epi.13779","volume":"58","author":"JA French","year":"2017","unstructured":"French JA, Koepp M, Naegelin Y, Vigevano F, Auvin S, Rho JM, Rosenberg E, Devinsky O, Olofsson PS, Dichter MA (2017) Clinical studies and anti-inflammatory mechanisms of treatments. Epilepsia 58:69\u201382. https:\/\/doi.org\/10.1111\/epi.13779","journal-title":"Epilepsia"},{"issue":"11","key":"1972_CR24","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/s41574-020-0386-0","volume":"16","author":"L Geng","year":"2020","unstructured":"Geng L, Lam KS, Xu A (2020) The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic. Nat Rev Endocrinol 16(11):654\u2013667. https:\/\/doi.org\/10.1038\/s41574-020-0386-0","journal-title":"Nat Rev Endocrinol"},{"key":"1972_CR25","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.redox.2016.12.024","volume":"11","author":"MA Gomez-Samano","year":"2017","unstructured":"Gomez-Samano MA, Grajales-G\u00f3mez M, Zuarth-V\u00e1zquez JM, Navarro-Flores MF, Mart\u00ednez-Saavedra M, Ju\u00e1rez-Le\u00f3n \u00d3A, Morales-Garc\u00eda MG, Enr\u00edquez-Estrada VM, G\u00f3mez-P\u00e9rez FJ, Cuevas-Ramos D (2017) Fibroblast growth factor 21 and its novel association with oxidative stress. Redox Biol 11:335\u2013341. https:\/\/doi.org\/10.1016\/j.redox.2016.12.024","journal-title":"Redox Biol"},{"issue":"11","key":"1972_CR26","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1046\/j.1440-1681.2002.03767.x","volume":"29","author":"AR Green","year":"2002","unstructured":"Green AR (2002 Nov) Why do neuroprotective drugs that are so promising in animals fail in the clinic? An industry perspective. Clin Exp Pharmacol Physiol 29(11):1030\u20131034. https:\/\/doi.org\/10.1046\/j.1440-1681.2002.03767.x","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"1972_CR27","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/s41467-022-28435-0","volume":"13","author":"SK Gunasekar","year":"2022","unstructured":"Gunasekar SK, Xie L, Kumar A, Hong J, Chheda PR, Kang C, Kern DM, My-Ta C, Maurer J, Heebink J, Gerber EE (2022) Small molecule SWELL1 complex induction improves glycemic control and nonalcoholic fatty liver disease in murine Type 2 diabetes. Nat Commun 13(1):784. https:\/\/doi.org\/10.1038\/s41467-022-28435-0","journal-title":"Nat Commun"},{"issue":"9","key":"1972_CR28","doi-asserted-by":"publisher","first-page":"4596","DOI":"10.3390\/ijms23094596","volume":"23","author":"E Gusev","year":"2022","unstructured":"Gusev E, Zhuravleva Y (2022) Inflammation: A new look at an old problem. Int J Mol Sci 23(9):4596. https:\/\/doi.org\/10.3390\/ijms23094596","journal-title":"Int J Mol Sci"},{"key":"1972_CR29","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3389\/fnmol.2020.00116","volume":"13","author":"MA Hannan","year":"2020","unstructured":"Hannan MA, Dash R, Sohag AA, Haque MN, Moon IS (2020) Neuroprotection against oxidative stress: phytochemicals targeting TrkB signaling and the Nrf2-ARE antioxidant system. Front Mol Neurosci 13:116. https:\/\/doi.org\/10.3389\/fnmol.2020.00116","journal-title":"Front Mol Neurosci"},{"key":"1972_CR30","doi-asserted-by":"publisher","unstructured":"He Y, Guo L, Wang L, Li Z, Lu R, Wan X, Liu N, Yan W, Wang H, Zhang Q, Xiong K (2026) Mitochondrial oxidative stress to PANoptosis: current evidence and therapeutic implications for neurological diseases. J Adv Res. https:\/\/doi.org\/10.1016\/j.jare.2026.02.023","DOI":"10.1016\/j.jare.2026.02.023"},{"issue":"2","key":"1972_CR31","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1042\/BST0350421","volume":"35","author":"DC Henshall","year":"2007","unstructured":"Henshall DC (2007) Apoptosis signalling pathways in seizure-induced neuronal death and epilepsy. Biochem Soc Trans 35(2):421\u2013423. https:\/\/doi.org\/10.1042\/BST0350421","journal-title":"Biochem Soc Trans"},{"issue":"4","key":"1972_CR32","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1038\/s41390-023-02652-9","volume":"94","author":"JR Herrmann","year":"2023","unstructured":"Herrmann JR, Kochanek PM, Vagni VA, Janesko-Feldman K, Stezoski J, Gorse K, Jackson TC (2023 Oct) FGF21 modulates hippocampal cold-shock proteins and CA2-subregion proteins in neonatal mice with hypoxia\u2013ischemia. Pediatr Res 94(4):1355\u20131364. https:\/\/doi.org\/10.1038\/s41390-023-02652-9","journal-title":"Pediatr Res"},{"issue":"3","key":"1972_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jphs.2020.07.011","volume":"144","author":"L Iovino","year":"2020","unstructured":"Iovino L, Tremblay ME, Civiero L (2020) Glutamate-induced excitotoxicity in Parkinson's disease: The role of glial cells. J Pharmacol Sci 144(3):151\u2013164. https:\/\/doi.org\/10.1016\/j.jphs.2020.07.011","journal-title":"J Pharmacol Sci"},{"key":"1972_CR34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.freeradbiomed.2015.03.020","volume":"84","author":"K Ji","year":"2015","unstructured":"Ji K, Zheng J, Lv J, Xu J, Ji X, Luo YB, Li W, Zhao Y, Yan C (2015) Skeletal muscle increases FGF21 expression in mitochondrial disorders to compensate for energy metabolic insufficiency by activating the mTOR\u2013YY1\u2013PGC1\u03b1 pathway. Free Radic Biol Med 84:161\u2013170. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2015.03.020","journal-title":"Free Radic Biol Med"},{"issue":"10","key":"1972_CR35","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.14202\/vetworld.2025.3041-3050","volume":"18","author":"PJ Jiji","year":"2025","unstructured":"Jiji PJ, Rai R, Kumar NA, Blossom V, Pai MM, Rai AR, Vadgaonkar R, Nayak SD (2025) Experimental models of epilepsy: a comprehensive review of mechanisms, translational relevance, and future directions. Vet World 18(10):3041. https:\/\/doi.org\/10.14202\/vetworld.2025.3041-3050","journal-title":"Vet World"},{"issue":"10","key":"1972_CR36","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1007\/s00204-023-03562-9","volume":"97","author":"K Jomova","year":"2023","unstructured":"Jomova K, Raptova R, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, Valko M (2023) Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging. Arch Toxicol 97(10):2499\u20132574. https:\/\/doi.org\/10.1007\/s00204-023-03562-9","journal-title":"Arch Toxicol"},{"key":"1972_CR37","doi-asserted-by":"publisher","unstructured":"Joshi CP, Agarwal S, Chauhan LS, Singla S, Baldi A, Pradhan J (2025) transformative approaches to epilepsy treatment: a review of recent developments. Acad J Clin Res Rep 2(2). https:\/\/doi.org\/10.59657\/3067-0438.brs.25.031","DOI":"10.59657\/3067-0438.brs.25.031"},{"key":"1972_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110439","volume":"129","author":"K Kang","year":"2020","unstructured":"Kang K, Xu P, Wang M, Chunyu J, Sun X, Ren G, Xiao W, Li D (2020) FGF21 attenuates neurodegeneration through modulating neuroinflammation and oxidant-stress. Biomed Pharmacother 129:110439. https:\/\/doi.org\/10.1016\/j.biopha.2020.110439","journal-title":"Biomed Pharmacother"},{"key":"1972_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.962561","volume":"9","author":"N Kaur","year":"2022","unstructured":"Kaur N, Gare SR, Shen J, Raja R, Fonseka O, Liu W (2022) Multi-organ FGF21-FGFR1 signaling in metabolic health and disease. Front Cardiovasc Med 9:962561. https:\/\/doi.org\/10.3389\/fcvm.2022.962561","journal-title":"Front Cardiovasc Med"},{"key":"1972_CR115","doi-asserted-by":"publisher","unstructured":"Kliewer SA, Mangelsdorf DJ (2019) A dozen years of discovery: insights into the physiology and pharmacology of FGF21. Cell metabolism 29(2):246\u201353. https:\/\/doi.org\/10.1016\/j.cmet.2019.01.004","DOI":"10.1016\/j.cmet.2019.01.004"},{"key":"1972_CR40","doi-asserted-by":"publisher","unstructured":"Kotah JM, Kater MS, Hoeijmakers L, Brosens N, Lesuis SL, Tandari R, Marchetto L, Yusaf E, Smit AB, Lucassen PJ, Krugers H (2023) Early-life stress exposure impacts the hippocampal synaptic proteome in a mouse model of Alzheimer\u2019s disease: age-and pathology-dependent effects on mitochondrial proteins. bioRxiv. https:\/\/doi.org\/10.1101\/2023.04.20.537660","DOI":"10.1101\/2023.04.20.537660"},{"issue":"1","key":"1972_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00109-022-02272-6","volume":"101","author":"S Kumar","year":"2023","unstructured":"Kumar S, Mehan S, Narula AS (2023) Therapeutic modulation of JAK-STAT, mTOR, and PPAR-\u03b3 signaling in neurological dysfunctions. J Mol Med 101(1):9\u201349. https:\/\/doi.org\/10.1007\/s00109-022-02272-6","journal-title":"J Mol Med"},{"key":"1972_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42255-025-01388-6","volume":"14","author":"M Kurade","year":"2025","unstructured":"Kurade M, Bobba-Alves N, Kelly C, Behnke A, Conklin Q, Juster RP, Hirano M, Trumpff C, Picard M (2025) Mitochondrial and psychosocial stress-related regulation of FGF21 in humans. Nat Metab 14:1\u20139. https:\/\/doi.org\/10.1038\/s42255-025-01388-6","journal-title":"Nat Metab"},{"issue":"4","key":"1972_CR43","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/epi4.12534","volume":"6","author":"AK Kwong","year":"2021","unstructured":"Kwong AK, Wong VC, Wong SS, Chu VL, Koene S, Smeitink J, Fung CW (2021) High FGF-21 level in a cohort of 22 patients with Dravet Syndrome\u2014possible relationship with the disease outcomes. Epilepsia Open 6(4):685\u2013693. https:\/\/doi.org\/10.1002\/epi4.12534","journal-title":"Epilepsia Open"},{"issue":"5","key":"1972_CR44","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.cmet.2017.09.005","volume":"26","author":"T Lan","year":"2017","unstructured":"Lan T, Morgan DA, Rahmouni K, Sonoda J, Fu X, Burgess SC, Holland WL, Kliewer SA, Mangelsdorf DJ (2017) FGF19, FGF21, and an FGFR1\/\u03b2-Klotho-activating antibody act on the nervous system to regulate body weight and glycemia. Cell Metab 26(5):709\u2013718. https:\/\/doi.org\/10.1016\/j.cmet.2017.09.005","journal-title":"Cell Metab"},{"key":"1972_CR119","doi-asserted-by":"publisher","unstructured":"Ledri M, Kokaia M 2026 Mar Gene therapy for epilepsy: An emerging, promising approach for a serious neurological disorder. J Intern Med. https:\/\/doi.org\/10.1111\/joim.70059","DOI":"10.1111\/joim.70059"},{"issue":"9","key":"1972_CR45","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202402797RR","volume":"39","author":"Q Li","year":"2025","unstructured":"Li Q, Zhang H, Xiao N, Liang G, Lin Y, Yang X, Yang J, Qian Z, Fu Y, Zhang C, Liu A (2025) Aging and lifestyle modifications for preventing aging-related diseases. FASEB J 39(9):e70575. https:\/\/doi.org\/10.1096\/fj.202402797RR","journal-title":"FASEB J"},{"issue":"34","key":"1972_CR46","doi-asserted-by":"publisher","first-page":"22752","DOI":"10.1021\/acsnano.4c06851","volume":"18","author":"J Lin","year":"2024","unstructured":"Lin J, Yu Z, Gao X (2024) Advanced noninvasive strategies for the brain delivery of therapeutic proteins and peptides. ACS Nano 18(34):22752\u201322779. https:\/\/doi.org\/10.1021\/acsnano.4c06851","journal-title":"ACS Nano"},{"issue":"1","key":"1972_CR47","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s11658-025-00807-6","volume":"30","author":"T Liu","year":"2025","unstructured":"Liu T, Wei J (2025) Oct FGF21 confers neuroprotection in Parkinson\u2019s disease by activating the FGFR1-sirt1 pathway. Cell Mol Biol Lett 30(1):127. https:\/\/doi.org\/10.1186\/s11658-025-00807-6","journal-title":"Cell Mol Biol Lett"},{"key":"1972_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.675725","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y, Deng J, Liu Y, Li W, Nie X (2021) FGF, mechanism of action, role in Parkinson\u2019s disease, and therapeutics. Front Pharmacol 12:675725. https:\/\/doi.org\/10.3389\/fphar.2021.675725","journal-title":"Front Pharmacol"},{"issue":"2","key":"1972_CR49","doi-asserted-by":"publisher","first-page":"106","DOI":"10.2174\/157015909788848857","volume":"7","author":"S Louis","year":"2009","unstructured":"Louis S, Erik K (2009) Minimizing AED adverse effects: improving quality of life in the interictal state in epilepsy care. Curr Neuropharmacol 7(2):106\u2013114. https:\/\/doi.org\/10.2174\/157015909788848857","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"1972_CR50","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.3390\/ijms24032928","volume":"24","author":"K \u0141ukasiuk","year":"2023","unstructured":"\u0141ukasiuk K, Laso\u0144 W (2023) Emerging molecular targets for anti-epileptogenic and epilepsy modifying drugs. Int J Mol Sci 24(3):2928. https:\/\/doi.org\/10.3390\/ijms24032928","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1972_CR51","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/14728222.2022.2039120","volume":"26","author":"K \u0141ukawski","year":"2022","unstructured":"\u0141ukawski K, Czuczwar SJ (2022) Emerging therapeutic targets for epilepsy: preclinical insights. Expert Opin Ther Targets. 26(3):193\u2013206. https:\/\/doi.org\/10.1080\/14728222.2022.2039120","journal-title":"Expert Opin Ther Targets."},{"key":"1972_CR52","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cytogfr.2017.08.001","volume":"38","author":"Y Luo","year":"2017","unstructured":"Luo Y, Ye S, Chen X, Gong F, Lu W, Li X (2017) Rush to the fire: FGF21 extinguishes metabolic stress, metaflammation and tissue damage. Cytokine Growth Factor Rev 38:59\u201365. https:\/\/doi.org\/10.1016\/j.cytogfr.2017.08.001","journal-title":"Cytokine Growth Factor Rev"},{"issue":"5","key":"1972_CR53","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3390\/brainsci13050784","volume":"13","author":"S Madireddy","year":"2023","unstructured":"Madireddy S, Madireddy S (2023) Therapeutic strategies to ameliorate neuronal damage in epilepsy by regulating oxidative stress, mitochondrial dysfunction, and neuroinflammation. Brain Sci 13(5):784. https:\/\/doi.org\/10.3390\/brainsci13050784","journal-title":"Brain Sci"},{"issue":"02","key":"1972_CR54","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/nep3.46","volume":"2","author":"JY Magdaleno Roman","year":"2024","unstructured":"Magdaleno Roman JY, Gonz\u00e1lez CC (2024) Glutamate and excitotoxicity in central nervous system disorders: ionotropic glutamate receptors as a target for neuroprotection. Neuroprotection 2(02):137\u2013150. https:\/\/doi.org\/10.1002\/nep3.46","journal-title":"Neuroprotection"},{"issue":"11","key":"1972_CR55","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.3389\/fimmu.2020.02021","volume":"10","author":"K Mallah","year":"2020","unstructured":"Mallah K, Couch C, Borucki DM, Toutonji A, Alshareef M, Tomlinson S (2020) Anti-inflammatory and neuroprotective agents in clinical trials for CNS disease and injury: where do we go from here? Front Immunol 10(11):2021. https:\/\/doi.org\/10.3389\/fimmu.2020.02021","journal-title":"Front Immunol"},{"issue":"4","key":"1972_CR56","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3390\/jpm13040623","volume":"13","author":"AM Manole","year":"2023","unstructured":"Manole AM, Sirbu CA, Mititelu MR, Vasiliu O, Lorusso L, Sirbu OM, Ionita Radu F (2023) State of the art and challenges in epilepsy\u2014a narrative review. J Pers Med 13(4):623. https:\/\/doi.org\/10.3390\/jpm13040623","journal-title":"J Pers Med"},{"issue":"8","key":"1972_CR57","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1136\/gutjnl-2023-331115","volume":"73","author":"A Mantovani","year":"2024","unstructured":"Mantovani A, Tilg H, Targher G (2024) Aug FGF-21 analogues for treatment of non-alcoholic steatohepatitis and fibrosis: a meta-analysis with fragility index of phase 2 randomised placebo-controlled trials. Gut. 73(8):1400\u20131402. https:\/\/doi.org\/10.1136\/gutjnl-2023-331115","journal-title":"Gut."},{"issue":"11","key":"1972_CR58","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1111\/j.1528-1167.2012.03637.x","volume":"53","author":"N Marchi","year":"2012","unstructured":"Marchi N, Granata T, Ghosh C, Janigro D (2012) Blood\u2013brain barrier dysfunction and epilepsy: pathophysiologic role and therapeutic approaches. Epilepsia 53(11):1877\u20131886. https:\/\/doi.org\/10.1111\/j.1528-1167.2012.03637.x","journal-title":"Epilepsia"},{"issue":"10","key":"1972_CR59","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s00109-020-01967-y","volume":"98","author":"A Maresca","year":"2020","unstructured":"Maresca A, Del Dotto V, Romagnoli M, La Morgia C, Di Vito L, Capristo M, Valentino ML, Carelli V, ER-MITO Study Group (2020) Expanding and validating the biomarkers for mitochondrial diseases. J Mol Med 98(10):1467\u20131478. https:\/\/doi.org\/10.1007\/s00109-020-01967-y","journal-title":"J Mol Med"},{"issue":"3","key":"1972_CR60","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.3390\/ijms27031175","volume":"27","author":"A Mazhit","year":"2026","unstructured":"Mazhit A, Akbay B, Trofimov A, Karapina O, Duysenbi S, Tokay T (2026) Epileptogenesis and epilepsy treatment: advances in mechanistic understanding, therapeutic approaches, and future perspectives. Int J Mol Sci 27(3):1175. https:\/\/doi.org\/10.3390\/ijms27031175","journal-title":"Int J Mol Sci"},{"key":"1972_CR61","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1002\/epi4.12576","volume":"7","author":"JS Medel-Matus","year":"2022","unstructured":"Medel-Matus JS, Orozco-Su\u00e1rez S, Escalante RG (2022) Factors not considered in the study of drug-resistant epilepsy: psychiatric comorbidities, age, and gender. Epilepsia Open 7:S81\u2013S93. https:\/\/doi.org\/10.1002\/epi4.12576","journal-title":"Epilepsia Open"},{"issue":"1","key":"1972_CR62","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s42494-020-00024-y","volume":"2","author":"F Meng","year":"2020","unstructured":"Meng F, Yao L (2020) The role of inflammation in epileptogenesis. Acta Epileptologica 2(1):15. https:\/\/doi.org\/10.1186\/s42494-020-00024-y","journal-title":"Acta Epileptologica"},{"issue":"6","key":"1972_CR63","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1111\/brv.12764","volume":"96","author":"G Morciano","year":"2021","unstructured":"Morciano G, Naumova N, Koprowski P, Valente S, Sard\u00e3o VA, Potes Y, Rimessi A, Wieckowski MR, Oliveira PJ (2021) The mitochondrial permeability transition pore: an evolving concept critical for cell life and death. Biol Rev 96(6):2489\u20132521. https:\/\/doi.org\/10.1111\/brv.12764","journal-title":"Biol Rev"},{"issue":"3","key":"1972_CR64","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1515\/revneuro-2016-0059","volume":"28","author":"M Navidhamidi","year":"2017","unstructured":"Navidhamidi M, Ghasemi M, Mehranfard N (2017) Epilepsy-associated alterations in hippocampal excitability. Rev Neurosci 28(3):307\u2013334. https:\/\/doi.org\/10.1515\/revneuro-2016-0059","journal-title":"Rev Neurosci"},{"issue":"95","key":"1972_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2025.102889","volume":"1","author":"A Nesari","year":"2025","unstructured":"Nesari A, Mardani E, Goudarzi M, Sabbagh S, Nooshabadi MR, Bakhtiari N, Malayeri AR (2025) The antioxidant and anticonvulsant effects of ellagic acid in kainic acid-induced temporal lobe epilepsy in mice. Tissue Cell 1(95):102889. https:\/\/doi.org\/10.1016\/j.tice.2025.102889","journal-title":"Tissue Cell"},{"key":"1972_CR120","doi-asserted-by":"publisher","unstructured":"Ng YH, Jamil SN, Sarian MN, Ahmed QU, Latip J, Lam SD, Feroz SR 2025 Jan 24.. Antiseizure medications: Advancements, challenges, and prospects in drug development. Current Neuropharmacology. https:\/\/doi.org\/10.2174\/011570159X323666241029171256","DOI":"10.2174\/011570159X323666241029171256"},{"issue":"8","key":"1972_CR66","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1038\/s12276-023-01046-5","volume":"55","author":"TT Nguyen","year":"2023","unstructured":"Nguyen TT, Wei S, Nguyen TH, Jo Y, Zhang Y, Park W, Gariani K, Oh CM, Kim HH, Ha KT, Park KS (2023) Mitochondria-associated programmed cell death as a therapeutic target for age-related disease. Exp Mol Med 55(8):1595\u20131619. https:\/\/doi.org\/10.1038\/s12276-023-01046-5","journal-title":"Exp Mol Med"},{"issue":"1","key":"1972_CR67","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1196\/annals.1427.002","volume":"1147","author":"DG Nicholls","year":"2008","unstructured":"Nicholls DG (2008) Oxidative stress and energy crises in neuronal dysfunction. Ann N Y Acad Sci 1147(1):53\u201360. https:\/\/doi.org\/10.1196\/annals.1427.002","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"1972_CR68","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3390\/antiox11081511","volume":"11","author":"R Pardillo-D\u00edaz","year":"2022","unstructured":"Pardillo-D\u00edaz R, P\u00e9rez-Garc\u00eda P, Castro C, Nunez-Abades P, Carrascal L (2022) Oxidative stress as a potential mechanism underlying membrane hyperexcitability in neurodegenerative diseases. Antioxidants 11(8):1511. https:\/\/doi.org\/10.3390\/antiox11081511","journal-title":"Antioxidants"},{"issue":"12","key":"1972_CR69","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1016\/j.freeradbiomed.2004.08.021","volume":"37","author":"M Patel","year":"2004","unstructured":"Patel M (2004) Mitochondrial dysfunction and oxidative stress: cause and consequence of epileptic seizures. Free Rad Biol Med 37(12):1951\u20131962. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2004.08.021","journal-title":"Free Rad Biol Med"},{"issue":"9","key":"1972_CR70","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.3390\/cells10092418","volume":"10","author":"P Phan","year":"2021","unstructured":"Phan P, Saikia BB, Sonnaila S, Agrawal S, Alraawi Z, Kumar TK, Iyer S (2021) The saga of endocrine FGFs. Cells 10(9):2418. https:\/\/doi.org\/10.3390\/cells10092418","journal-title":"Cells"},{"issue":"8","key":"1972_CR71","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3390\/antiox9080647","volume":"9","author":"A Picca","year":"2020","unstructured":"Picca A, Calvani R, Coelho-Junior HJ, Landi F, Bernabei R, Marzetti E (2020 Jul) Mitochondrial dysfunction, oxidative stress, and neuroinflammation: intertwined roads to neurodegeneration. Antioxidants 9(8):647. https:\/\/doi.org\/10.3390\/antiox9080647","journal-title":"Antioxidants"},{"issue":"8","key":"1972_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.783659","volume":"23","author":"AM Poff","year":"2021","unstructured":"Poff AM, Moss S, Soliven M, D'Agostino DP (2021) Ketone supplementation: meeting the needs of the brain in an energy crisis. Front Nutr 23(8):783659. https:\/\/doi.org\/10.3389\/fnut.2021.783659","journal-title":"Front Nutr"},{"issue":"21","key":"1972_CR73","doi-asserted-by":"publisher","first-page":"13318","DOI":"10.3390\/ijms232113318","volume":"23","author":"E Prida","year":"2022","unstructured":"Prida E, Alvarez-Delgado S, Perez-Lois R, Soto-Tielas M, Estany-Gestal A, Fern\u00f8 J, Seoane LM, Quinones M, Al-Massadi O (2022) Liver brain interactions: focus on FGF21 a systematic review. Int J Mol Sci 23(21):13318. https:\/\/doi.org\/10.3390\/ijms232113318","journal-title":"Int J Mol Sci"},{"key":"1972_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2019.106546","volume":"101","author":"S Rahman","year":"2019","unstructured":"Rahman S (2019) Advances in the treatment of mitochondrial epilepsies. Epilepsy Behav 101:106546. https:\/\/doi.org\/10.1016\/j.yebeh.2019.106546","journal-title":"Epilepsy Behav"},{"issue":"1","key":"1972_CR75","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12974-018-1192-7","volume":"15","author":"A Rana","year":"2018","unstructured":"Rana A, Musto AE (2018) The role of inflammation in the development of epilepsy. J Neuroinflammation 15(1):144. https:\/\/doi.org\/10.1186\/s12974-018-1192-7","journal-title":"J Neuroinflammation"},{"key":"1972_CR76","doi-asserted-by":"publisher","first-page":"7210","DOI":"10.2741\/3223","volume":"13","author":"R Rao","year":"2008","unstructured":"Rao R (2008) Oxidative stress-induced disruption of epithelial and endothelial tight junctions. Front Biosci 13:7210. https:\/\/doi.org\/10.2741\/3223","journal-title":"Front Biosci"},{"issue":"4","key":"1972_CR77","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3390\/pharmaceutics17040456","volume":"17","author":"M Rasekh","year":"2025","unstructured":"Rasekh M, Arshad MS, Ahmad Z (2025) Advances in drug delivery integrated with regenerative medicine: innovations, challenges, and future frontiers. Pharmaceutics 17(4):456. https:\/\/doi.org\/10.3390\/pharmaceutics17040456","journal-title":"Pharmaceutics"},{"key":"1972_CR78","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3389\/fncel.2013.00115","volume":"7","author":"DS Reddy","year":"2013","unstructured":"Reddy DS (2013) Role of hormones and neurosteroids in epileptogenesis. Front Cell Neurosci 7:115. https:\/\/doi.org\/10.3389\/fncel.2013.00115","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"1972_CR79","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.celrep.2018.07.023","volume":"24","author":"LM Restelli","year":"2018","unstructured":"Restelli LM, Oettinghaus B, Halliday M, Agca C, Licci M, Sironi L, Savoia C, Hench J, Tolnay M, Neutzner A, Schmidt A (2018 Aug) Neuronal mitochondrial dysfunction activates the integrated stress response to induce fibroblast growth factor 21. Cell Rep 24(6):1407\u20131414. https:\/\/doi.org\/10.1016\/j.celrep.2018.07.023","journal-title":"Cell Rep"},{"key":"1972_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.753753","volume":"12","author":"A Riva","year":"2021","unstructured":"Riva A, Golda A, Balagura G, Amadori E, Vari MS, Piccolo G, Iacomino M, Lattanzi S, Salpietro V, Minetti C, Striano P (2021) New trends and most promising therapeutic strategies for epilepsy treatment. Front Neurol 12:753753. https:\/\/doi.org\/10.3389\/fneur.2021.753753","journal-title":"Front Neurol"},{"key":"1972_CR81","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.yhbeh.2016.08.006","volume":"85","author":"P Sa-Nguanmoo","year":"2016","unstructured":"Sa-Nguanmoo P, Tanajak P, Kerdphoo S, Satjaritanun P, Wang X, Liang G, Li X, Jiang C, Pratchayasakul W, Chattipakorn N, Chattipakorn SC (2016) FGF21 improves cognition by restored synaptic plasticity, dendritic spine density, brain mitochondrial function and cell apoptosis in obese-insulin resistant male rats. Horm Behav 85:86\u201395. https:\/\/doi.org\/10.1016\/j.yhbeh.2016.08.006","journal-title":"Horm Behav"},{"issue":"91","key":"1972_CR82","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.yebeh.2018.05.039","volume":"1","author":"S Schubert-Bast","year":"2019","unstructured":"Schubert-Bast S, Rosenow F, Klein KM, Reif PS, Kieslich M, Strzelczyk A (2019) The role of mTOR inhibitors in preventing epileptogenesis in patients with TSC: current evidence and future perspectives. Epilepsy Behav 1(91):94\u201398. https:\/\/doi.org\/10.1016\/j.yebeh.2018.05.039","journal-title":"Epilepsy Behav"},{"issue":"1","key":"1972_CR83","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1089\/neu.2019.6422","volume":"37","author":"RA Shahror","year":"2020","unstructured":"Shahror RA, Linares GR, Wang Y, Hsueh SC, Wu CC, Chuang DM, Chiang YH, Chen KY (2020) Transplantation of mesenchymal stem cells overexpressing fibroblast growth factor 21 facilitates cognitive recovery and enhances neurogenesis in a mouse model of traumatic brain injury. J Neurotrauma 37(1):14\u201326. https:\/\/doi.org\/10.1089\/neu.2019.6422","journal-title":"J Neurotrauma"},{"issue":"5","key":"1972_CR84","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.3390\/biomedicines11051499","volume":"11","author":"NA Shnayder","year":"2023","unstructured":"Shnayder NA, Grechkina VV, Trefilova VV, Efremov IS, Dontceva EA, Narodova EA, Petrova MM, Soloveva IA, Tepnadze LE, Reznichenko PA, Al-Zamil M (2023) Valproate-induced metabolic syndrome. Biomedicines 11(5):1499. https:\/\/doi.org\/10.3390\/biomedicines11051499","journal-title":"Biomedicines"},{"issue":"570","key":"1972_CR85","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.neuroscience.2025.02.023","volume":"27","author":"MM Shokr","year":"2025","unstructured":"Shokr MM, Eladawy RM (2025) HMGB1: Different secretion pathways with pivotal role in epilepsy and major depressive disorder. Neuroscience 27(570):55\u201367. https:\/\/doi.org\/10.1016\/j.neuroscience.2025.02.023","journal-title":"Neuroscience"},{"issue":"1","key":"1972_CR86","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4068\/cmj.2025.61.1.32","volume":"61","author":"MM Sikder","year":"2025","unstructured":"Sikder MM, Li X, Akumwami S, Labony SA (2025) Reactive oxygen species: role in pathophysiology, and mechanism of endogenous and dietary antioxidants during oxidative stress. Chonnam Med J 61(1):32. https:\/\/doi.org\/10.4068\/cmj.2025.61.1.32","journal-title":"Chonnam Med J"},{"issue":"3","key":"1972_CR87","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0098-2997(99)00008-4","volume":"20","author":"VP Skulachev","year":"1999","unstructured":"Skulachev VP (1999) Mitochondrial physiology and pathology; concepts of programmed death of organelles, cells and organisms. Mol Asp Med 20(3):139\u2013184. https:\/\/doi.org\/10.1016\/S0098-2997(99)00008-4","journal-title":"Mol Asp Med"},{"key":"1972_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2024.153974","volume":"509","author":"P Soluyanova","year":"2024","unstructured":"Soluyanova P, Del Pozo M, Moro-Casta\u00f1o E, Marco-Hern\u00e1ndez AV, Castell JV, Jover R (2024) A microRNA signature for valproate-induced steatosis in human hepatocytes and its application to predict fatty liver in paediatric epileptic patients on valproate therapy. Toxicology 509:153974. https:\/\/doi.org\/10.1016\/j.tox.2024.153974","journal-title":"Toxicology"},{"issue":"10","key":"1972_CR89","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1093\/brain\/awx168","volume":"140","author":"HE Steele","year":"2017","unstructured":"Steele HE, Horvath R, Lyon JJ, Chinnery PF (2017) Monitoring clinical progression with mitochondrial disease biomarkers. Brain 140(10):2530\u20132540. https:\/\/doi.org\/10.1093\/brain\/awx168","journal-title":"Brain"},{"issue":"1","key":"1972_CR90","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s42494-023-00137-0","volume":"5","author":"KT Sumadewi","year":"2022","unstructured":"Sumadewi KT, Harkitasari S, Tjandra DC (2022) Biomolecular mechanisms of epileptic seizures and epilepsy: a review. Acta Epileptol 5(1):28. https:\/\/doi.org\/10.1186\/s42494-023-00137-0","journal-title":"Acta Epileptol"},{"issue":"37","key":"1972_CR91","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.2174\/1381612823666170926113754","volume":"23","author":"G Terrone","year":"2017","unstructured":"Terrone G, Salamone A, Vezzani A (2017) Oct Inflammation and epilepsy: preclinical findings and potential clinical translation. Curr Pharm Des 23(37):5569\u20135576. https:\/\/doi.org\/10.2174\/1381612823666170926113754","journal-title":"Curr Pharm Des"},{"issue":"24","key":"1972_CR117","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.3390\/cells11244129","volume":"11","author":"MR Tesiye","year":"2022","unstructured":"Tesiye MR, Gol M, Fadardi MR, Kani SN, Costa AM, Ghasemi-Kasman M, Biagini G (2022) Therapeutic potential of mesenchymal stem cells in the treatment of epilepsy and their interaction with antiseizure medications. Cells 11(24):4129. https:\/\/doi.org\/10.3390\/cells11244129","journal-title":"Cells"},{"issue":"2","key":"1972_CR92","doi-asserted-by":"publisher","first-page":"114","DOI":"10.14744\/ijmb.2024.16768","volume":"7","author":"N Tiwari","year":"2024","unstructured":"Tiwari N, Tiwari A, Mehra L (2024) Fibroblast growth factors: properties, biosynthesis, biological functions, therapeutic applications and engineering. Int J Med Biochem 7(2):114\u2013126. https:\/\/doi.org\/10.14744\/ijmb.2024.16768","journal-title":"Int J Med Biochem"},{"issue":"6","key":"1972_CR93","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fncel.2012.00023","volume":"15","author":"V Tretter","year":"2012","unstructured":"Tretter V, Mukherjee J, Maric HM, Schindelin H, Sieghart W, Moss SJ (2012) Gephyrin, the enigmatic organizer at GABAergic synapses. Front Cell Neurosci 15(6):23. https:\/\/doi.org\/10.3389\/fncel.2012.00023","journal-title":"Front Cell Neurosci"},{"key":"1972_CR94","doi-asserted-by":"publisher","unstructured":"Upadhayay S, Soni D, Dhureja M, Temgire P, Kumar V, Arthur R, Kumar P (2025) Role of fibroblast growth factors in neurological disorders: insight into therapeutic approaches and molecular mechanisms. Mol Neurobiol:1\u201320. https:\/\/doi.org\/10.1007\/s12035-025-04962-x","DOI":"10.1007\/s12035-025-04962-x"},{"issue":"15","key":"1972_CR95","doi-asserted-by":"publisher","first-page":"12488","DOI":"10.3390\/ijms241512488","volume":"24","author":"D Valenti","year":"2023","unstructured":"Valenti D, Vacca RA (2023) Brain mitochondrial bioenergetics in genetic neurodevelopmental disorders: focus on Down, Rett and Fragile X syndromes. Int J Mol Sci 24(15):12488. https:\/\/doi.org\/10.3390\/ijms241512488","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1972_CR96","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s11033-021-06896-8","volume":"49","author":"S Vishwakarma","year":"2022","unstructured":"Vishwakarma S, Singh S, Singh TG (2022) Pharmacological modulation of cytokines correlating neuroinflammatory cascades in epileptogenesis. Mol Biol Rep 49(2):1437\u20131452. https:\/\/doi.org\/10.1007\/s11033-021-06896-8","journal-title":"Mol Biol Rep"},{"issue":"6","key":"1972_CR97","doi-asserted-by":"publisher","first-page":"4702","DOI":"10.1007\/s12035-017-0663-7","volume":"55","author":"Q Wang","year":"2018","unstructured":"Wang Q, Yuan J, Yu Z, Lin LI, Jiang Y, Cao Z, Zhuang P, Whalen MJ, Song B, Wang XJ, Li X (2018) FGF21 attenuates high-fat diet-induced cognitive impairment via metabolic regulation and anti-inflammation of obese mice. Mol Neurobiol 55(6):4702\u20134717. https:\/\/doi.org\/10.1007\/s12035-017-0663-7","journal-title":"Mol Neurobiol"},{"key":"1972_CR98","doi-asserted-by":"publisher","first-page":"1169019","DOI":"10.3389\/fphar.2023.1169019","volume":"14","author":"H Wang","year":"2023","unstructured":"Wang H, Su J, Yu M, Xia Y, Wei Y (2023) PGC-1\u03b1 in osteoarthritic chondrocytes: from mechanism to target of action. Front Pharmacol 14:1169019. https:\/\/doi.org\/10.3389\/fphar.2023.1169019","journal-title":"Front Pharmacol"},{"key":"1972_CR99","doi-asserted-by":"publisher","unstructured":"Wang DX, Huang WT, Shi JF, Liu F, Jiang WY, Chen KY, Zhang SY, Li XK, Lin L (2025) FGF21, a modulator of astrocyte reactivity, protects against ischemic brain injury through anti-inflammatory and neurotrophic pathways. Acta Pharmacol Sin:1-8. https:\/\/doi.org\/10.1038\/s41401-024-01462-x","DOI":"10.1038\/s41401-024-01462-x"},{"issue":"2","key":"1972_CR100","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/brainsci16020151","volume":"16","author":"H Wang","year":"2026","unstructured":"Wang H, Wen X, Yan M, Li R, Mao D, Tian X (2026) FGF\u2013FGFR signaling in Parkinson\u2019s disease: mechanistic links to ferroptosis and neuroprotection. Brain Sci 16(2):151. https:\/\/doi.org\/10.3390\/brainsci16020151","journal-title":"Brain Sci"},{"issue":"3","key":"1972_CR101","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11064-026-04809-4","volume":"51","author":"Z Wang","year":"2026","unstructured":"Wang Z, Hu X, Liang Y, Tan G, Fan W, Peng J, Ma YN, Xia Y (2026) Olfactory mucosa MSCs-derived exosomal RPL6 attenuates seizure-induced neuronal damage via FGF2-mediated oxidative stress and mitophagy. Neurochem Res 51(3):191. https:\/\/doi.org\/10.1007\/s11064-026-04809-4","journal-title":"Neurochem Res"},{"issue":"2","key":"1972_CR102","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nn.3602","volume":"17","author":"SG Waxman","year":"2014","unstructured":"Waxman SG, Zamponi GW (2014) Regulating excitability of peripheral afferents: emerging ion channel targets. Nat Neurosci 17(2):153\u2013163. https:\/\/doi.org\/10.1038\/nn.3602","journal-title":"Nat Neurosci"},{"issue":"4","key":"1972_CR103","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3233\/JAD-150759","volume":"49","author":"EM Weekman","year":"2016","unstructured":"Weekman EM, Wilcock DM (2016) Matrix metalloproteinase in blood-brain barrier breakdown in dementia. J Alzheimers Dis 49(4):893\u2013903. https:\/\/doi.org\/10.3233\/JAD-150759","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1972_CR104","doi-asserted-by":"publisher","first-page":"4241","DOI":"10.1038\/s41598-018-22456-w","volume":"8","author":"Y Weng","year":"2018","unstructured":"Weng Y, Ishino T, Sievers A, Talukdar S, Chabot JR, Tam A, Duan W, Kerns K, Sousa E, He T, Logan A (2018) Glyco-engineered long acting FGF21 variant with optimal pharmaceutical and pharmacokinetic properties to enable weekly to twice monthly subcutaneous dosing. Sci Rep 8(1):4241. https:\/\/doi.org\/10.1038\/s41598-018-22456-w","journal-title":"Sci Rep"},{"issue":"35","key":"1972_CR105","doi-asserted-by":"publisher","first-page":"5510","DOI":"10.2174\/1381612820666140306103401","volume":"20","author":"YT Wu","year":"2014","unstructured":"Wu YT, Wu SB, Wei YH (2014) Metabolic reprogramming of human cells in response to oxidative stress: implications in the pathophysiology and therapy of mitochondrial diseases. Curr Pharm Des 20(35):5510\u20135526. https:\/\/doi.org\/10.2174\/1381612820666140306103401","journal-title":"Curr Pharm Des"},{"key":"1972_CR106","doi-asserted-by":"publisher","first-page":"1358646","DOI":"10.3389\/fphar.2024.1358646","volume":"15","author":"Y Yan","year":"2024","unstructured":"Yan Y, Ran X, Zhou Z, Gu Y, Wang R, Qiu C, Sun Y, Wang J, Xiao J, Lu Y, Wang J (2024) FGF21 inhibits ferroptosis caused by mitochondrial damage to promote the repair of peripheral nerve injury. Front Pharmacol 15:1358646. https:\/\/doi.org\/10.3389\/fphar.2024.1358646","journal-title":"Front Pharmacol"},{"issue":"5","key":"1972_CR107","doi-asserted-by":"publisher","first-page":"6369","DOI":"10.1007\/s12035-024-04673-9","volume":"62","author":"Q Yan","year":"2025","unstructured":"Yan Q, Li XJ, Wang QQ, Jia W, Wang SL (2025) FGF21 exhibits neuroprotective effects by promoting 5-HT1AR-FGFR1 heteroreceptor complexes and triggering MEK1\/2-ERK1\/2 signaling pathway. Mol Neurobiol 62(5):6369\u20136382. https:\/\/doi.org\/10.1007\/s12035-024-04673-9","journal-title":"Mol Neurobiol"},{"key":"1972_CR108","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3389\/fphar.2020.00690","volume":"11","author":"C Yang","year":"2020","unstructured":"Yang C, Shi Z, You L, Du Y, Ni J, Yan D (2020) Neuroprotective effect of catalpol via anti-oxidative, anti-inflammatory, and anti-apoptotic mechanisms. Front Pharmacol 11:690. https:\/\/doi.org\/10.3389\/fphar.2020.00690","journal-title":"Front Pharmacol"},{"issue":"13","key":"1972_CR109","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.778527","volume":"22","author":"C Yang","year":"2021","unstructured":"Yang C, Wang W, Deng P, Li C, Zhao L, Gao H (2021) Fibroblast growth factor 21 modulates microglial polarization that attenuates neurodegeneration in mice and cellular models of Parkinson's disease. Front Aging Neurosci 22(13):778527. https:\/\/doi.org\/10.3389\/fnagi.2021.778527","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"1972_CR110","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s11010-015-2358-6","volume":"403","author":"Y Yu","year":"2015","unstructured":"Yu Y, Bai F, Liu Y, Yang Y, Yuan Q, Zou D, Qu S, Tian G, Song L, Zhang T, Li S (2015) Fibroblast growth factor (FGF21) protects mouse liver against D-galactose-induced oxidative stress and apoptosis via activating Nrf2 and PI3K\/Akt pathways. Mol Cell Biochem 403(1):287\u2013299. https:\/\/doi.org\/10.1007\/s11010-015-2358-6","journal-title":"Mol Cell Biochem"},{"issue":"11","key":"1972_CR111","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.3390\/molecules27113516","volume":"27","author":"M Zehravi","year":"2022","unstructured":"Zehravi M, Kabir J, Akter R, Malik S, Ashraf GM, Tagde P, Ramproshad S, Mondal B, Rahman MH, Mohan AG, Cavalu S (2022) A prospective viewpoint on neurological diseases and their biomarkers. Molecules 27(11):3516. https:\/\/doi.org\/10.3390\/molecules27113516","journal-title":"Molecules"},{"key":"1972_CR112","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.biopha.2018.03.100","volume":"103","author":"S Zhang","year":"2018","unstructured":"Zhang S, Yu D, Wang M, Huang T, Wu H, Zhang Y, Zhang T, Wang W, Yin J, Ren G, Li D (2018) FGF21 attenuates pulmonary fibrogenesis through ameliorating oxidative stress in vivo and in vitro. Biomed Pharmacother 103:1516\u20131525. https:\/\/doi.org\/10.1016\/j.biopha.2018.03.100","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1972_CR113","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12974-025-03363-0","volume":"22","author":"G Zhang","year":"2025","unstructured":"Zhang G, Wei H, Zhao A, Yan X, Zhang X, Gan J, Guo M, Wang J, Zhang F, Jiang Y, Liu X (2025) Mitochondrial DNA leakage: underlying mechanisms and therapeutic implications in neurological disorders. J Neuroinflammation 22(1):34. https:\/\/doi.org\/10.1186\/s12974-025-03363-0","journal-title":"J Neuroinflammation"},{"key":"1972_CR114","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.852416","volume":"13","author":"G Zhu","year":"2022","unstructured":"Zhu G, Wang X, Chen L, Lenahan C, Fu Z, Fang Y, Yu W (2022) Crosstalk between the oxidative stress and glia cells after stroke: from mechanism to therapies. Front Immunol 13:852416. https:\/\/doi.org\/10.3389\/fimmu.2022.852416","journal-title":"Front Immunol"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01972-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-026-01972-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-026-01972-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:23:04Z","timestamp":1790655784000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-026-01972-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":120,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1972"],"URL":"https:\/\/doi.org\/10.1007\/s11011-026-01972-z","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"assertion":[{"value":"11 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No conflicts of interest to declare.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"229"}}